A -- DEPARTMENT OF DEFENSE NEUROFIBROMATOSIS RESEARCH PROGRAM FOR FISCAL YEAR 2001

Notice Date

March 28, 2001

Contracting Office

Director, USAMRAA, 820 Chandler St, Fort Detrick, MD 21702-5014

ZIP Code

21702-5014

Solicitation Number

CBD-NFRP-0328

Point of Contact

Kathryn M. Dunn, Contracting Officer, 301-619-7354, e-mail: kathy.dunn@amedd.army.mil

Description

The Fiscal Year (FY) 2001 Defense Appropriations Act provides $17 million to the Department of Defense Neurofibromatosis Research Program (NFRP) to support innovative research directed toward decreasing the impact of neurofibromatosis 1 (NF1) and NF2. This program has been administered since FY96 by the U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP). Proposals submitted to the FY01 NFRP must be submitted electronically by July 25, 2001 at 4:00 p.m. Eastern Time. The NFRP will offer the following award mechanisms: New Investigator Awards Idea Awards Investigator-Initiated Research Awards Clinical Trial Awards Therapeutic Development Awards The Therapeutic Development Award Mechanism, intended to support the development and evaluation of preclinical animal or cell-based model systems for NF1 and NF2, is new this year. The overall goal of this award mechanism is to allow NF investigators to develop the skills and generate the preclinical data necessary to conduct clinical trials after completion of the research. Detailed descriptions of each of these mechanisms, submission requirements, and evaluation criteria can be found in the FY01 NFRP Program Announcement. This document can be downloaded from the CDMRP website (http://cdmrp.army.mil). For more information about the NFRP, NFRP awardees, NFRP Program Announcements and other CDMRP sponsored programs and events, please visit the CDMRP website (http://cdmrp.army.mil).

Record

Loren Data Corp. 20010330/ASOL014.HTM (W-087 SN50H5A8)